Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients

Guideline for the laboratory diagnosis of functional iron deficiency

Wayne Thomas, Rod F Hinchliffe, Carol Briggs et al. · British Journal of Haematology · 2013 · 388 citations · Full text

Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study

Guy Rostoker, Mireille Griuncelli, Christelle Loridon et al. · The American Journal of Medicine · 2012 · 160 citations

Hemodialysis, Urology, Erythropoiesis-stimulating Agents +14

A randomized, controlled parallel‐group trial on efficacy and safety of iron sucrose (Venofer®) vs iron gluconate (Ferrlecit®) in haemodialysis patients treated with rHuEpo

Markus Kosch, Udo Bahner, Helga Bettger et al. · Nephrology Dialysis Transplantation · 2001 · 87 citations · Full text

Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis

Ajay Gupta, Neeta B. Amin, Anatole Besarab et al. · Kidney International · 1999 · 62 citations

Hemodialysis, Urology, Renal Function +11

The exchange of Fe3+ between pyrophosphate and transferrin. Probing the nature of an intermediate complex with stopped flow kinetics, rapid multimixing, and electron paramagnetic resonance spectroscopy.

Richard E. Cowart, Susan Keene Swope, Tatt Tuck Loh et al. · Journal of Biological Chemistry · 1986 · 57 citations · Full text